Made-in-Alberta sanitizing device kills SARS-CoV-2 virus in 60 seconds
A new made-in-Alberta sanitization product aimed at stopping the spread of SARS-CoV-2 will soon be in use at the Edmonton International Airport and government offices in Calgary and Edmonton, thanks to a partnership with scientists at the University of Alberta’s Biosafety Level 3 Lab.
Researchers at University of Toronto, McMaster study COVID-19 testing protocols for arriving international travellers
McMaster HealthLabs, a COVID-19-focused non-profit organization associated with researchers at McMaster University, the Research Institute of St. Joe’s Hamilton...
COVID-19 transmission chains in the UK accurately traced using genomic epidemiology
Their analysis draws on >50k virus genome sequences – 26k of which were gathered through the COVID-19 Genomics UK (COG-UK) consortium
The flu, a cold, allergies or COVID-19? How to decipher symptoms
Let’s say you have a runny nose, headache and cough. Are they signs of COVID-19 or just a run-of-the-mill common cold?
Online job advertisements continue to bounce back
Looking for a job? The COVID-19 impact on the Australian labour market has been daunting and dispiriting, but as we round out the year, online job vacancies are increasing.
Tumultuous Times: National economics forum to ask the big questions
The University of Waikato is set to host a national economics conference in person and via livestream on 3 and 4 March to ask the big questions about the future of New Zealand’s economy.
Is a new breed of CEO required to lead in a post-COVID world?
Future CEOs will require extra skills to successfully manage themselves and their organisations, says UNSW Business School’s Frederik Anseel.
Digital tool to dial back COVID-19 anxiety, depression and alcohol use
With more than a third of Australians now drinking alcohol daily, compared to 6 per cent pre-COVID-19, researchers are developing a digital tool to help communities manage the ongoing impacts of COVID-19.
Oxford University breakthrough on global COVID-19 vaccine
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019...
It will be a long, long wait for Covid herd immunity
Opinion: The ongoing crisis over the Covid-positive person who visited Wellington from Sydney raises questions about the Government’s zero Covid stance, writes Professor Ananish Chaudhuri.
